23 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Penicilliosis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #regimens #medications ... #pharmacology #
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Clinical Disease Indication ... Trypanosomiasis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
• Recommend pharmacologic ... therapy • Education ... measures, fall prevention ... benefits and risks of medications ... Treatment #Algorithm #Management
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Encephalitis in HIV-AIDS Indications ... infections #HIVAIDS #management ... pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Indications ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Biologic therapy for eosinophilic asthma 
• Mepolizumab (Nucala) 
  • Anti-lL-5, 100 mg SQ q4
Biologic therapy ... asthma #Biologic #therapy ... #Medications #pharmacology ... #pulmonary #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis Indication ... Leishmaniasis #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... Primary Infection Indications ... #Zoster #VZV #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology